Physician profile

Parham Parto

Cardiovascular Disease · Newport Beach, CA

NPI 1629212378

$14,395.99

in general payments reported to CMS, 2019-2025

28 companies · $3,973 in 2025

The $3,973 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,282.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $5,435.24 2019-2025 Avvigo Guidance System, Emerge Push, Emblem Mri S-Icd
Abbott Laboratories $2,332.33 2019-2025 Jot Dx, Confirm Rx, Esprit
Shockwave Medical, INC $1,286.98 2024-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Abiomed $1,197.83 2021-2025 Impella
Angiodynamics, INC. $682.41 2019-2025 Auryon Laser System 100-120 Vac
Novartis Pharmaceuticals Corporation $578.75 2019-2025
Becton, Dickinson and Company $462.49 2025 Rotarexs 6 F X 135 Cm
Medtronic, INC. $457.75 2024-2025 In.Pact Admiral, Hawkone, Chocolate Pta Balloon Catheter
Biotronik INC. $375.98 2019
Cook Medical LLC $369.48 2019-2024 Advance, Flexor, Rosen
Cvrx, INC. $270.53 2021
Philips North America LLC $205.95 2019-2025 (5044) Mcot, IV Other, (Bs0) Mechanical Atherectomy
Amgen INC. $153.01 2021-2025 Repatha
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $100.35 2019-2024 Lifevest
Kiniksa Pharmaceuticals International, Plc $67.21 2024 Arcalyst
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $55.65 2024 Xarelto
Bayer Healthcare Pharmaceuticals INC. $53.58 2024-2025
Regeneron Healthcare Solutions, INC. $41.16 2019-2021
Merz North America, INC. $41.07 2024
Cleerly, INC. $37.28 2025 Cleerly Labs, Cleerly Ischemia
Pfizer INC. $31.66 2019-2025
Actelion Pharmaceuticals US, INC. $30.40 2019-2020
Lexicon Pharmaceuticals, INC. $27.41 2024
Recor Medical INC $24.20 2025 Paradise Ultrasound Renal Denervation System
Amarin Pharma, INC. $23.30 2021
Astrazeneca Pharmaceuticals LP $20.90 2020
Ge Healthcare $16.73 2019
E.R. Squibb & Sons, L.L.C. $16.36 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Parham Parto

$14,395.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $3,973 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/950441/parham-parto

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.